Treatment Outcomes of Ranibizumab versus Aflibercept for Neovascular Age-Related Macular Degeneration

201923 citationsJournal Article

Authors

Good health and well-being

Published in: Ophthalmology

Volume 127, Issue 3, pp. 369-376

Field-Weighted Citation Impact: 3.27